BREAKING NEWS:

Stronger Together
to Fight Rare Disease

Fibrocell has joined with Castle Creek Pharma to deliver new therapies for patients with high unmet need.

Learn More

 

Our proprietary personalized biologics approach

Targeting the underlying cause of diseases affecting the skin and connective tissue to bring relief to patients and their families

Learn More

personalized biologics approach

Our focus on the patient drives everything we do and as a result, our path forward is clear: to develop game-changing cell and gene therapies for localized treatment of the underlying cause of debilitating diseases.

— John Maslowski, President and Chief Executive Officer

Our robust development pipeline of personalized biologics for localized treatment

Applying the unique characteristics of autologous fibroblasts to cell and gene therapies

 

Photo left: Courtesy of debra–The Dystrophic Epidermolysis Bullosa Research Association of America. Used with permission.

Recent Happenings


Our News and Events

    patient8-287x284 patient14-189x284 patient1-287x284 patient13-228x284 patient12-322x284 inset-patient-RDEB-476-284 patient6-315x284 patient4-322x284